首页> 外文会议>ACS Symposium on Polymeric Delivery of Therapeutics >Polymers in Nano Pharmaceutical Materials
【24h】

Polymers in Nano Pharmaceutical Materials

机译:纳米药物中的聚合物

获取原文

摘要

With the advent of nanotechnology, research on pharmaceuticals has experienced a paradigm shift. As opposed to traditional materials, new nanomaterials and nanoparticles are currently being investigated as drug delivery systems. This chapter provides an overview of contemporary approaches for producing nano-drugs. The discussion is divided into three parts: (1) the motivation for nano materials in pharmaceutical applications, (2) nano pharmaceuticals produced by "top down" processes that involve size reduction, and (3) processes that use "bottom up" assembly of nano materials from smaller sub units. In the "bottom up" assembly the distinction between thermodynamically controlled assembly and kinetically controlled assembly is presented with emphasis on the kinetically controlled assembly of polymer protected nanoparticles produced by Flash NanoPrecipitation. The advantages and disadvantages of the various approaches are discussed. Introduction
机译:随着纳米技术的出现,药品的研究经历了范式转变。与传统材料相反,目前正在研究新的纳米材料和纳米颗粒作为药物递送系统。本章概述了当代生产纳米药物的方法。讨论分为三部分:(1)药物应用中纳米材料的动机,(2)纳米药物,由“自上而下”过程,涉及尺寸减少的过程,以及使用“自下而上”组装的(3)来自较小子单元的纳米材料。在“自下而上”组装中,热力学控制的组件和动力控制组件之间的区别在于通过闪蒸纳米沉淀制备的聚合物保护纳米粒子的动力学控制组件。讨论了各种方法的优点和缺点。介绍

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号